Target intelligence / Profile preview

Bacterial nitroreductase (NTR)

Target
NTR
Molecular classification
Enzyme, Oxidoreductase, Flavoprotein
01

Overview

Bacterial nitroreductases (NTRs) are a family of flavin-containing enzymes that catalyze the reduction of nitroaromatic and nitroheterocyclic compounds using NAD(P)H as an electron donor. These enzymes are widely exploited in medicine, particularly in antimicrobial therapy and cancer gene therapy. In antimicrobial applications, bacterial NTRs activate prodrugs like nitrofurantoin, metronidazole, pretomanid, and delamanid into highly reactive cytotoxic intermediates that damage bacterial DNA and proteins, leading to cell death. In oncology, bacterial NTRs (such as E. coli NfsB) are utilized in gene-directed enzyme prodrug therapy (GDEPT) and antibody-directed enzyme prodrug therapy (ADEPT). In these strategies, the NTR gene is selectively delivered to tumor cells, which then express the enzyme and locally activate prodrugs like CB1954 into potent DNA cross-linking agents, minimizing systemic side effects. However, challenges remain, including potential off-target toxicity from the bystander effect and the development of resistance through bacterial mutations in NTR-encoding genes.

Other names
Bacterial flavoprotein/nitroreductase enzymesNitroreductaseOxygen-insensitive nitroreductaseNfsANfsBDdnDeazaflavin-dependent nitroreductaseFMN-dependent nitroreductase
02

Mechanism of action

Bacterial nitroreductases catalyze the NAD(P)H-dependent reduction of nitroaromatic compounds and nitroimidazoles. This enzymatic reduction converts relatively non-toxic prodrugs into highly reactive, cytotoxic intermediates (such as nitroso, hydroxylamine, or amine derivatives) that cause DNA damage, DNA cross-linking, and cell death.

03

Biological functions

Cell deathApoptosisOther
04

Disease associations

InfectionCancer
05

Safety considerations

Off-target toxicity in healthy tissuesBystander effect toxicityDevelopment of drug resistance due to NTR mutationsSystemic toxicity of activated metabolites
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

Nitroreductase expression levelTumor hypoxiaNTR gene presence

Beyond the preview

Go deeper on Bacterial nitroreductase (NTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial nitroreductase (NTR).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call